MARKET

BSX

BSX

Boston Scien Cp
NYSE
77.71
+0.71
+0.92%
After Hours: 77.90 +0.19 +0.24% 19:57 06/21 EDT
OPEN
77.10
PREV CLOSE
77.00
HIGH
77.81
LOW
76.90
VOLUME
9.94M
TURNOVER
0
52 WEEK HIGH
77.81
52 WEEK LOW
48.35
MARKET CAP
114.25B
P/E (TTM)
64.88
1D
5D
1M
3M
1Y
5Y
Haemonetics Undervalued As It Passes Into A Period Of Softer Reported Growth
Seeking Alpha · 15h ago
Should You Investigate Boston Scientific Corporation (NYSE:BSX) At US$77.00?
Boston Scientific Corporation (NYSE:BSX) saw a double-digit share price rise of over 10% in the past month. The company is trading around its 52-week high and is around 11.85% above its fair value. The stock seems fairly valued at the moment, but is there still an opportunity to buy? We take a look at Boston Scientific's outlook and value to see if the opportunity still exists.
Simply Wall St · 17h ago
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
NASDAQ · 18h ago
McKesson (MCK) Reaches 52-Week High: What's Aiding the Stock?
NASDAQ · 19h ago
DexCom's (DXCM) G6 CGM System Combines With AID in Netherlands
NASDAQ · 19h ago
The Case for Hybrid Work: More Innovation and Greater Employee Engagement -- Journal Report
The Wall Street Journal · 22h ago
Zacks Industry Outlook Highlights Boston Scientific, ResMed, Lantheus and Haemonetics
NASDAQ · 23h ago
February 2025 Options Now Available For Boston Scientific (BSX)
NASDAQ · 1d ago
More
About BSX
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. The Cardiovascular segment includes Cardiology and Peripheral Interventions. The Company's Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions.

Webull offers Boston Scientific Corporation stock information, including NYSE: BSX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BSX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BSX stock methods without spending real money on the virtual paper trading platform.